In light of the FAF1 downregulation and the loss of epithelial differentiation that we clearly observed in different breast cancer models, we found the clinical relevance of FAF1 in the percentage of distant metastasis-free survival of breast cancer patients where the cutoff by FAF1 expression correlates with prognosis (Fig. 1j). This evidence concerns the gene FAF1 and breast carcinoma.